Clear ×
Advanced Biomed Inc. ADVB

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 14, 2026 8-K 4 signals fired
Other
Use Of Proceeds Disclosure Amendment Modification Waiver Clause New York Jurisdiction Clause Corporate Authority Representation
Feb 13, 2026 10-Q 14 signals fired
Other
Financing Activities Cash Flow Disclosure Nol Carryforward Expiration Disclosure Institutional Investment Cash Flow Statement Investing Activities Reverse Stock Split Effected Nol Tax Credit Carryforward Net Loss Reported No Icfr Changes In Quarter Codm Segment Reporting Disclosure Material Weakness Internal Controls Valuation Allowance Deferred Tax Disclosure Ipo Or Capital Raising Completion Critical Accounting Policies Disclosure
Core
Enrollment Failure
Feb 2, 2026 8-K 17 signals fired · top 15
Other
Corporate Organization And Standing Representation New York Jurisdiction Clause Amendment Modification Waiver Clause No Broker Fees Representation Sanctions Compliance Representation Closing Deliverables Specified Fcpa Compliance Representation Regulation D Offering Disclosure Coinvestment Exemptive Order Requested Institutional Investment Tax Advisor Consultation Urged Corporate Authority Representation Investment Company Act Exemption Claimed Restricted Stock Certificate Legend Required Survival Of Representations Warranties Clause
Jan 27, 2026 8-K 3 signals fired
Other
Board Fairness Determination Corporate Authority Representation Equity Plan Board Approval Conditional On Shareholder Vote
Jan 21, 2026 8-K 2 signals fired
Other
Reverse Stock Split Effected Nasdaq Minimum Bid Price Delisting Notice
Dec 30, 2025 8-K 19 signals fired · top 15
Other
New York Jurisdiction Clause Corporate Organization And Standing Representation Closing Deliverables Specified Corporate Authority Representation Amendment Modification Waiver Clause Non Assignment Clause Board Fairness Determination Director Officer Indemnification Provision Confidential Information Return Obligation Ai Diagnostics Investment No Broker Fees Representation Ip Assignment To Company Equity Plan Board Approval Conditional On Shareholder Vote Conflicted Defense Counsel Provision Indemnification Consent Requirement
Nov 19, 2025 10-Q 15 signals fired
Other
Net Loss Reported Cash Flow Statement Investing Activities Administrative Efficiency Financing Activities Cash Flow Disclosure No Icfr Changes In Quarter Codm Segment Reporting Disclosure Material Weakness Internal Controls Foreign Currency Translation Accounting Disclosure Burn Rate Controlled Valuation Allowance Deferred Tax Disclosure Prc Overseas Listing Regulatory Disclosure Critical Accounting Policies Disclosure
Core
Enrollment Failure Lead Asset Progress
Biotech v3
Ind Submission Planned